3-V Biosciences Inc | VCINVEST DATA

INACTIVE/DISSOLVED

Founded

31 Dec 2006

Address

3-V Biosciences Inc
1050 Hamilton Court
Menlo Park, CA 94025
United States

Open Map

3-V Biosciences Inc
2225 E Bayshore Road
Suite 200
Palo Alto, CA 94303
United States

Open Map

3-V Biosciences Inc
2225 E. Bayshore Rd.
Suite 200
Palo Alto, CA 94303
United States

Open Map

3-V Biosciences Inc
1050 Hamilton Court
Menlo Park, CA 94025
United States

Open Map

3-V Biosciences Inc
1050 Hamilton Court
Menlo Park, CA 94025
United States

Open Map Open Map Open Map Open Map Open Map

Phone

Website

http://www.3vbio.com

Industry

2100 Manufacture of pharmaceuticals, medicinal chemical and botanical products

VCID: 106498

Profile

Corporate information

Renamed to

Sagimet Biosciences

Registration country

Official identities

US CIK 0001400118

Investment activity status

Not investing

Company type

Biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases.

Funding

Funding rounds

Series B USD 30,000,000

USD 30,000,000 (10 Jul 2019)

Investor		Profile	Country	Notes
	Kleiner Perkins Caufield & Byers LLC	Venture capital firm.	United States	Initial investment. Round participant.
	The Column Group			Initial investment. Round participant.
	New Enterprise Associates Inc	Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies.	United States	Follow-on investment. Round participant.

Series C USD 20,000,000

USD 20,000,000 (21 Jun 2013)

Investor		Profile	Country	Notes
	Kleiner Perkins Caufield & Byers LLC	Venture capital firm.	United States	Initial investment. Round participant.
	New Enterprise Associates Inc	Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies.	United States	Follow-on investment. Round participant.

Venture USD 8,089,000

USD 8,089,000 (1 Oct 2012)

Investor		Profile	Country	Notes
	Kleiner Perkins Caufield & Byers LLC	Venture capital firm.	United States	Initial investment. Round participant.
	New Enterprise Associates Inc	Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies.	United States	Follow-on investment. Round participant.

Venture USD 20,000,000

USD 20,000,000 (5 Jan 2012)

Investor		Profile	Country	Notes
	Kleiner Perkins Caufield & Byers LLC	Venture capital firm.	United States	Initial investment. Round participant.
	New Enterprise Associates Inc	Global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors and geographies.	United States	Initial investment. Round participant.

Venture

(1 Jan 2012)

Series B

(1 Jul 2009)